• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮质类固醇在感染性角膜炎治疗中的应用:简要综述。

Corticosteroids in the Management of Infectious Keratitis: A Concise Review.

机构信息

Department of Ophthalmology, All India Institute of Medical Sciences, Bhopal, India.

Department of Ophthalmology, College of Veterinary Medicine and Mason Eye Institute, School of Medicine, University of Missouri, Columbia, Missouri, USA.

出版信息

J Ocul Pharmacol Ther. 2021 Oct;37(8):452-463. doi: 10.1089/jop.2021.0040. Epub 2021 Aug 26.

DOI:10.1089/jop.2021.0040
PMID:34448619
Abstract

Microbial keratitis is devastating corneal morbidity with a variable spectrum of clinical manifestations depending on the infective etiology. Irrespective of the varied presentation delayed treatment can lead to severe visual impairment resulting from corneal ulceration, possible perforation, and subsequent scarring. Corticosteroids with a potent anti-inflammatory activity reduce host inflammation, thus minimizing resultant scarring while improving ocular symptoms. These potential effects of corticosteroids have been applied widely to treat various corneal diseases ranging from vernal keratoconjunctivitis to dry eye disease. However, antimicrobial therapy remains the mainstay of treatment in microbial keratitis, whereas the use of adjunctive topical corticosteroid therapy remains a matter of debate. Understandably, the use of topical corticosteroids is a double-edged sword with pros and cons in the treatment of microbial keratitis. Herein we review the rationale for and against the use and safety of topical corticosteroids in the treatment of infective keratitis. Important considerations, including type, dose, efficacy, the timing of initiation of corticosteroids, use of concomitant antimicrobial agents, and duration of corticosteroid therapy while prescribing corticosteroids for microbial keratitis, have been discussed. This review intends to provide new insights into the therapeutic utility of steroids as adjunctive treatment of corneal ulcer.

摘要

微生物性角膜炎是一种破坏性的角膜疾病,其临床表现因感染病因而异。无论表现形式如何,如果治疗不及时,都可能导致严重的视力损害,包括角膜溃疡、穿孔和随后的瘢痕形成。具有强大抗炎作用的皮质类固醇可减轻宿主炎症,从而最大限度地减少瘢痕形成,同时改善眼部症状。这些皮质类固醇的潜在作用已广泛应用于治疗各种角膜疾病,从春季角结膜炎到干眼症。然而,在微生物性角膜炎的治疗中,抗菌治疗仍然是主要方法,而局部皮质类固醇治疗的辅助应用仍然存在争议。可以理解的是,局部皮质类固醇的使用在治疗微生物性角膜炎时是一把双刃剑,既有优点也有缺点。本文综述了在治疗感染性角膜炎时使用和不使用局部皮质类固醇的理由和安全性。在为微生物性角膜炎开皮质类固醇处方时,还讨论了重要的考虑因素,包括皮质类固醇的类型、剂量、疗效、皮质类固醇开始使用的时间、与抗菌药物的联合使用以及皮质类固醇治疗的持续时间。本文旨在为类固醇作为角膜溃疡辅助治疗的治疗效果提供新的见解。

相似文献

1
Corticosteroids in the Management of Infectious Keratitis: A Concise Review.皮质类固醇在感染性角膜炎治疗中的应用:简要综述。
J Ocul Pharmacol Ther. 2021 Oct;37(8):452-463. doi: 10.1089/jop.2021.0040. Epub 2021 Aug 26.
2
Update on the Management of Infectious Keratitis.感染性角膜炎的治疗进展
Ophthalmology. 2017 Nov;124(11):1678-1689. doi: 10.1016/j.ophtha.2017.05.012. Epub 2017 Sep 21.
3
Steroids in the Management of Infectious Keratitis.类固醇在感染性角膜炎治疗中的应用。
Cornea. 2023 Nov 1;42(11):1333-1339. doi: 10.1097/ICO.0000000000003340. Epub 2023 Jul 4.
4
Rationale for adjunctive topical corticosteroids in bacterial keratitis.细菌性角膜炎中辅助性局部使用皮质类固醇的基本原理。
Arch Ophthalmol. 2009 Jan;127(1):97-102. doi: 10.1001/archophthalmol.2008.504.
5
Pharmacological treatment for infectious corneal ulcers.感染性角膜溃疡的药物治疗。
Expert Opin Pharmacother. 2013 Apr;14(5):543-60. doi: 10.1517/14656566.2013.775248. Epub 2013 Feb 27.
6
Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT).用于细菌性角膜炎的皮质类固醇:角膜溃疡类固醇试验(SCUT)。
Arch Ophthalmol. 2012 Feb;130(2):143-50. doi: 10.1001/archophthalmol.2011.315. Epub 2011 Oct 10.
7
Use of adjunctive topical corticosteroids in bacterial keratitis.局部应用皮质类固醇辅助治疗细菌性角膜炎
Curr Opin Ophthalmol. 2016 Jul;27(4):353-7. doi: 10.1097/ICU.0000000000000273.
8
Nocardia keratitis: clinical course and effect of corticosteroids.诺卡氏角膜炎:临床病程和皮质类固醇的作用。
Am J Ophthalmol. 2012 Dec;154(6):934-939.e1. doi: 10.1016/j.ajo.2012.06.001. Epub 2012 Sep 5.
9
Clinical aspects and prognosis of mixed microbial (bacterial and fungal) keratitis.混合微生物(细菌和真菌)角膜炎的临床特点和预后。
Cornea. 2011 Apr;30(4):409-13. doi: 10.1097/ICO.0b013e3181f23704.
10
Identification and molecular characterization of Subramaniula asteroides causing human fungal keratitis: a case report.鉴定并分子特征分析导致人类真菌性角膜炎的 Subramaniula asteroides:一例病例报告。
BMC Infect Dis. 2021 Jan 18;21(1):82. doi: 10.1186/s12879-021-05768-7.

引用本文的文献

1
The pathogenesis, risk factors, diagnosis and treatment of Acanthamoeba keratitis.棘阿米巴角膜炎的发病机制、危险因素、诊断与治疗
Front Med (Lausanne). 2025 Jul 24;12:1559224. doi: 10.3389/fmed.2025.1559224. eCollection 2025.
2
Exploring Symptom Experience and Management Strategies Among Patients with Corneal Ulcers Based on Symptom Management Theory: A Qualitative Study.基于症状管理理论探索角膜溃疡患者的症状体验与管理策略:一项定性研究
Patient Prefer Adherence. 2025 May 16;19:1449-1462. doi: 10.2147/PPA.S515296. eCollection 2025.
3
Analyze interleukin-1β, interleukin-6, and tumor necrosis factor-α levels in dry eye and the therapeutic effect of cyclosporine A.
分析干眼症中白细胞介素-1β、白细胞介素-6和肿瘤坏死因子-α的水平以及环孢素A的治疗效果。
World J Clin Cases. 2024 Sep 6;12(25):5665-5672. doi: 10.12998/wjcc.v12.i25.5665.
4
Spironolactone Eyedrop Favors Restoration of Corneal Integrity after Wound Healing in the Rat.螺内酯滴眼液有助于大鼠伤口愈合后角膜完整性的恢复。
Pharmaceuticals (Basel). 2023 Oct 12;16(10):1446. doi: 10.3390/ph16101446.
5
Efficacy and Safety of Ophthalmic Preparations of Glucocorticoids in Patients with Epidemic Keratoconjunctivitis: A Systematic Review and Meta-analysis.糖皮质激素眼用制剂治疗流行性角结膜炎患者的疗效与安全性:一项系统评价和Meta分析
Ther Innov Regul Sci. 2023 May;57(3):476-483. doi: 10.1007/s43441-022-00479-w. Epub 2022 Nov 22.
6
Corneal stromal repair and regeneration.角膜基质的修复和再生。
Prog Retin Eye Res. 2022 Nov;91:101090. doi: 10.1016/j.preteyeres.2022.101090. Epub 2022 May 29.